The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas

Gliomas are the most common primary malignant intracranial brain tumors. Their proliferative and invasive behavior is controlled by various epigenetic mechanisms. 5-hydroxymethylcytosine (5-hmC) is one of the epigenetic DNA modifications that employs ten-eleven translocation (TET) enzymes to its oxi...

Full description

Bibliographic Details
Main Authors: Aneta Brągiel-Pieczonka, Gabriela Lipka, Angelika Stapińska-Syniec, Michał Czyżewski, Katarzyna Żybura-Broda, Michał Sobstyl, Marcin Rylski, Marta Grabiec
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.621460/full
_version_ 1811334197183250432
author Aneta Brągiel-Pieczonka
Gabriela Lipka
Angelika Stapińska-Syniec
Michał Czyżewski
Katarzyna Żybura-Broda
Michał Sobstyl
Marcin Rylski
Marcin Rylski
Marta Grabiec
author_facet Aneta Brągiel-Pieczonka
Gabriela Lipka
Angelika Stapińska-Syniec
Michał Czyżewski
Katarzyna Żybura-Broda
Michał Sobstyl
Marcin Rylski
Marcin Rylski
Marta Grabiec
author_sort Aneta Brągiel-Pieczonka
collection DOAJ
description Gliomas are the most common primary malignant intracranial brain tumors. Their proliferative and invasive behavior is controlled by various epigenetic mechanisms. 5-hydroxymethylcytosine (5-hmC) is one of the epigenetic DNA modifications that employs ten-eleven translocation (TET) enzymes to its oxidation. Previous studies demonstrated altered expression of 5-hmC across gliomagenesis. However, its contribution to the initiation and progression of human gliomas still remains unknown. To characterize the expression profiles of 5-hmC and TET in human glioma samples we used the EpiJET 5-hmC and 5-mC Analysis Kit, quantitative real-time PCR, and Western blot analysis. A continuous decline of 5-hmC levels was observed in solid tissue across glioma grades. However, in glioblastoma (GBM), we documented uncommon heterogeneity in 5-hmC expression. Further analysis showed that the levels of TET proteins, but not their transcripts, may influence the 5-hmC abundance in GBM. Early tumor-related biomarkers may also be provided by the study of aberrant DNA hydroxymethylation in the blood of glioma patients. Therefore, we explored the patterns of TET transcripts in plasma samples and we found that their profiles were variously regulated, with significant value for TET2. The results of our study confirmed that DNA hydroxymethylation is an important mechanism involved in the pathogenesis of gliomas, with particular reference to glioblastoma. Heterogeneity of 5-hmC and TET proteins expression across GBM may provide novel insight into define subtype-specific patterns of hydroxymethylome, and thus help to interpret the heterogeneous outcomes of patients with the same disease.
first_indexed 2024-04-13T17:04:21Z
format Article
id doaj.art-7df8e5650a8a4e05ac37574cc88f558c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T17:04:21Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-7df8e5650a8a4e05ac37574cc88f558c2022-12-22T02:38:31ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-04-011210.3389/fonc.2022.621460621460The Profiles of Tet-Mediated DNA Hydroxymethylation in Human GliomasAneta Brągiel-Pieczonka0Gabriela Lipka1Angelika Stapińska-Syniec2Michał Czyżewski3Katarzyna Żybura-Broda4Michał Sobstyl5Marcin Rylski6Marcin Rylski7Marta Grabiec8Department of Clinical Cytology, Centre of Postgraduate Medical Education, Warsaw, PolandDepartment of Clinical Cytology, Centre of Postgraduate Medical Education, Warsaw, PolandDepartment of Neurosurgery, Institute of Psychiatry and Neurology, Warsaw, PolandDepartment of Neurosurgery, Institute of Psychiatry and Neurology, Warsaw, PolandDepartment of Clinical Cytology, Centre of Postgraduate Medical Education, Warsaw, PolandDepartment of Neurosurgery, Institute of Psychiatry and Neurology, Warsaw, PolandDepartment of Clinical Cytology, Centre of Postgraduate Medical Education, Warsaw, PolandDepartment of Radiology, Institute of Psychiatry and Neurology, Warsaw, PolandDepartment of Clinical Cytology, Centre of Postgraduate Medical Education, Warsaw, PolandGliomas are the most common primary malignant intracranial brain tumors. Their proliferative and invasive behavior is controlled by various epigenetic mechanisms. 5-hydroxymethylcytosine (5-hmC) is one of the epigenetic DNA modifications that employs ten-eleven translocation (TET) enzymes to its oxidation. Previous studies demonstrated altered expression of 5-hmC across gliomagenesis. However, its contribution to the initiation and progression of human gliomas still remains unknown. To characterize the expression profiles of 5-hmC and TET in human glioma samples we used the EpiJET 5-hmC and 5-mC Analysis Kit, quantitative real-time PCR, and Western blot analysis. A continuous decline of 5-hmC levels was observed in solid tissue across glioma grades. However, in glioblastoma (GBM), we documented uncommon heterogeneity in 5-hmC expression. Further analysis showed that the levels of TET proteins, but not their transcripts, may influence the 5-hmC abundance in GBM. Early tumor-related biomarkers may also be provided by the study of aberrant DNA hydroxymethylation in the blood of glioma patients. Therefore, we explored the patterns of TET transcripts in plasma samples and we found that their profiles were variously regulated, with significant value for TET2. The results of our study confirmed that DNA hydroxymethylation is an important mechanism involved in the pathogenesis of gliomas, with particular reference to glioblastoma. Heterogeneity of 5-hmC and TET proteins expression across GBM may provide novel insight into define subtype-specific patterns of hydroxymethylome, and thus help to interpret the heterogeneous outcomes of patients with the same disease.https://www.frontiersin.org/articles/10.3389/fonc.2022.621460/fullepigenetics5-hydroxymethylcytosineten-eleven translocation enzymesbrain tumorsglioblastoma
spellingShingle Aneta Brągiel-Pieczonka
Gabriela Lipka
Angelika Stapińska-Syniec
Michał Czyżewski
Katarzyna Żybura-Broda
Michał Sobstyl
Marcin Rylski
Marcin Rylski
Marta Grabiec
The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
Frontiers in Oncology
epigenetics
5-hydroxymethylcytosine
ten-eleven translocation enzymes
brain tumors
glioblastoma
title The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
title_full The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
title_fullStr The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
title_full_unstemmed The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
title_short The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas
title_sort profiles of tet mediated dna hydroxymethylation in human gliomas
topic epigenetics
5-hydroxymethylcytosine
ten-eleven translocation enzymes
brain tumors
glioblastoma
url https://www.frontiersin.org/articles/10.3389/fonc.2022.621460/full
work_keys_str_mv AT anetabragielpieczonka theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT gabrielalipka theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT angelikastapinskasyniec theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT michałczyzewski theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT katarzynazyburabroda theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT michałsobstyl theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT marcinrylski theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT marcinrylski theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT martagrabiec theprofilesoftetmediateddnahydroxymethylationinhumangliomas
AT anetabragielpieczonka profilesoftetmediateddnahydroxymethylationinhumangliomas
AT gabrielalipka profilesoftetmediateddnahydroxymethylationinhumangliomas
AT angelikastapinskasyniec profilesoftetmediateddnahydroxymethylationinhumangliomas
AT michałczyzewski profilesoftetmediateddnahydroxymethylationinhumangliomas
AT katarzynazyburabroda profilesoftetmediateddnahydroxymethylationinhumangliomas
AT michałsobstyl profilesoftetmediateddnahydroxymethylationinhumangliomas
AT marcinrylski profilesoftetmediateddnahydroxymethylationinhumangliomas
AT marcinrylski profilesoftetmediateddnahydroxymethylationinhumangliomas
AT martagrabiec profilesoftetmediateddnahydroxymethylationinhumangliomas